Ampersand Biomedicines Revenue

Biotechnology Research • United States • 51-100 Employees

Ampersand Biomedicines revenue & valuation

Annual revenue	$1,000,000
Revenue per employee	$18,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,200,000
Total funding	$115,000,000

Key Contacts at Ampersand Biomedicines

Jason Gardner

Ceo

Michael Jacobs

Associate Director, Human Resources

Pratibha Singh

Associate Director, In Vivo Pharmacology, Ampersand Biomedicines

Andrew Kinloch

Associate Director Platform Innovation

Company overview

Headquarters	United States
Website	ampersand.bio
NAICS	541714
Founded	2021
Employees	51-100
Socials

Ampersand Biomedicines Email Formats

Ampersand Biomedicines uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@ampersand.bio), used 100% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@ampersand.bio	100%

About Ampersand Biomedicines

Ampersand Biomedicines enables a new way of designing programmable medicines that work precisely where needed in the body and nowhere else. The company’s state-of-the-art computationally powered Address, Navigate, Design (AND)™ Platform continually learns the rules for identifying optimal localizer targets and refines its ability to design across the complex space of localizers and actuators. The result is increasingly sophisticated AND-Body™ therapeutics that are engineered across the physical constraints of molecules and the biological characteristics of the targets to effectively target the site of disease without affecting healthy tissue or cells. Ampersand Biomedicines was founded in 2020 at Flagship Labs, a unit of Flagship Pioneering.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Senior

Director

Employees by Department

Ampersand Biomedicines has 18 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore Ampersand Biomedicines's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-04-07	1	$50,000,000
2025-04-19	5	$65,000,000

Funding Insights

$115,000,000

Total funding amount

$65,000,000

Most recent funding amount

Number of funding rounds

Ampersand Biomedicines Tech Stack

Discover the technologies and tools that power Ampersand Biomedicines's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Adobe Fonts

Font scripts

Google Hosted Libraries

CDN

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Cookiebot

Cookie compliance

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

Vimeo

Video players

Cookie Control

Cookie compliance

Webflow

Page builders

Frequently asked questions

Ampersand Biomedicines is located in US.

Ampersand Biomedicines generates an estimated annual revenue of $1,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Ampersand Biomedicines has an estimated valuation of $3,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Ampersand Biomedicines was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Ampersand Biomedicines has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Ampersand Biomedicines has raised a total of $115,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.